Tiumbio

Developer of small molecules therapeutics

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2016 groups51 employees language tiumbio.com

Innovation

13 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 336 times.

YearFilings
20161
20175
20186
20194
20204
20211
20222
20234
20243
20255
20261

Social engagement

Social engagement: 432 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include KTB Network, Korea Investment Holdings, Korea Development Bank Europe, IMM Investment.

Investor typeCountShare
Venture capital542%
Private equity18%
Bank & private debt18%
Other / undisclosed542%

Hiring activity

Hires periodically

4 roles tracked across 3 of the last 12 months

7 May 2026 · Clinical Project Specialist / Associate

17 Apr 2026 · CMO

11 Mar 2026 · HPLC, ADC, ADC, LNA

Based on job postings tracked across public sources.

Coming soon